Literature DB >> 27304245

Novel Analysis of the Oral Treprostinil Combination Therapy Trial Data.

R James White1, Youlan Rao2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27304245     DOI： 10.1164/rccm.201602-0274LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  6 in total

1.  Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation.

Authors:  Franck F Rahaghi; Jeremy P Feldman; Roblee P Allen; Victor Tapson; Zeenat Safdar; Vijay P Balasubramanian; Shelley Shapiro; Michael A Mathier; Jean M Elwing; Murali M Chakinala; R James White
Journal:  Pulm Circ       Date:  2017-03-21       Impact factor: 3.017

2.  EXPRESS: Long term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics.

Authors:  R James White; Keyur Parikh; Roblee Allen; Jeremy Feldman; Carlos Jerjez-Sanchez; Lei Pan; Ann M Keogh; Carmine Dario Vizza; Shelly M Shapiro; Kathryn Gordon; Meredith Broderick; Sonja Bartolome
Journal:  Pulm Circ       Date:  2019-07-10       Impact factor: 3.017

3.  Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations.

Authors:  Gautam Ramani; Steven Cassady; Eric Shen; Meredith Broderick; Allie Wasik; Qun Sui; Andrew Nelsen
Journal:  Pulm Circ       Date:  2020-10-27       Impact factor: 3.017

4.  Impact of four times daily dosing of oral treprostinil on tolerability and daily dose achieved in pulmonary hypertension.

Authors:  James C Coons; Cheryl Bunner; David C Ishizawar; Michael G Risbano; Belinda Rivera-Lebron; Michael A Mathier; Stephen Y Chan; Marc A Simon
Journal:  Pulm Circ       Date:  2018 Jan-Mar       Impact factor: 3.017

5.  Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience.

Authors:  James C Coons; Taylor Miller
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

6.  Dosing characteristics of oral treprostinil in real-world clinical practice.

Authors:  Vijay P Balasubramanian; Chad R Messick; Meredith Broderick; Andrew C Nelsen
Journal:  Pulm Circ       Date:  2018-03-27       Impact factor: 3.017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.